New synthetic AICAR derivatives with enhanced AMPK and ACC activation
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New synthetic AICAR derivatives with enhanced AMPK and ACC activation
Authors
Keywords
-
Journal
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
Volume 31, Issue 5, Pages 748-753
Publisher
Informa UK Limited
Online
2015-10-08
DOI
10.3109/14756366.2015.1063622
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Small Molecule Adenosine 5′-Monophosphate Activated Protein Kinase (AMPK) Modulators and Human Diseases
- (2014) Sandeep Rana et al. JOURNAL OF MEDICINAL CHEMISTRY
- New Insight into Adiponectin Role in Obesity and Obesity-Related Diseases
- (2014) Ersilia Nigro et al. Biomed Research International
- Chimeric Beta-Defensin Analogs, Including the Novel 3NI Analog, Display Salt-Resistant Antimicrobial Activity and Lack Toxicity in Human Epithelial Cell Lines
- (2013) Olga Scudiero et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Adiponectin affects lung epithelial A549 cell viability counteracting TNFa and IL-1ß toxicity through AdipoR1
- (2013) Ersilia Nigro et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Synthesis of New Acadesine (AICA-riboside) Analogues Having Acyclic d-Ribityl or 4-Hydroxybutyl Chains in Place of the Ribose
- (2013) Stefano D'Errico et al. MOLECULES
- AMPK activators inhibit the proliferation of human melanomas bearing the activated MAPK pathway
- (2012) Carlotta Petti et al. MELANOMA RESEARCH
- Abstract A209: The nucleoside analogue acadesine exerts antitumoral activity and cooperates with anti-CD20 monoclonal antibodies in in vitro and in vivo models of mantle cell lymphoma.
- (2012) A. Montraveta et al. MOLECULAR CANCER THERAPEUTICS
- Solid-Phase Synthesis of a New Diphosphate 5-Aminoimidazole-4-carboxamide Riboside (AICAR) Derivative and Studies toward Cyclic AICAR Diphosphate Ribose
- (2011) Stefano D’Errico et al. MOLECULES
- AICA-riboside (acadesine), an activator of AMP-activated protein kinase with potential for application in hematologic malignancies
- (2010) Eric Van Den Neste et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Phospholipase D1 Mediates AMP-Activated Protein Kinase Signaling for Glucose Uptake
- (2010) Jong Hyun Kim et al. PLoS One
- A solid-phase approach to the synthesis of N-1-alkyl analogues of cyclic inosine-diphosphate-ribose (cIDPR)
- (2010) Giorgia Oliviero et al. TETRAHEDRON
- AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease
- (2009) Aaron K. F. Wong et al. CLINICAL SCIENCE
- 2′-O-Alkyl Derivatives and 5′-Analogues of 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) as Potential Hsp90 Inhibitors
- (2009) Antonio Bracci et al. EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
- AMPK activator, AICAR, inhibits palmitate-induced apoptosis in osteoblast
- (2008) Ji-Eun Kim et al. BONE
- Synthesis of 4-N-alkyl and ribose-modified AICAR analogues on solid support
- (2008) Giorgia Oliviero et al. TETRAHEDRON
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now